SecBot SecBot
SECBOTREPLAY Home › Report › VRTX

VRTX · Seven executives at Vertex Pharmaceuticals sold shares in a coordinated…

VERTEX PHARMACEUTICALS INC / MA · CLUSTER filed Feb 24, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Feb 24, 2026 at 19:00 ET

Seven executives at Vertex Pharmaceuticals sold shares in a coordinated cluster over a 3-day window, with total open-market sales amounting to $4.4 million. All transactions were direct sales at market prices, including a $1.2 million sale by the Chief Commercial Officer. The activity represents less than 0.01% of the company's $123.5B market cap and aligns with routine insider selling patterns.

  • 8 open-market share sales by 8 different insiders over 7 days
  • Total value of sales: $4,453,244.64
  • All sellers are C-suite executives, including EVPs across commercial, legal, scientific, technical, and medical functions
  • No purchases, grants, or derivative exercises in the cluster

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access